Swollen lymph node in neck following 1st dose; Immediate tremor in bottom lips following 1st dose; numbness; Rashes; itching; Medicine Taste; This is a spontaneous report received from a contactable reporter(s) (Consumer or other non HCP). The reporter is the patient.  A 39 year-old female patient (not pregnant) received bnt162b2 (BNT162B2), administered in arm left, administration date 09Aug2021 11:15 (Lot number: FA7484) at the age of 39 years as dose 1, single for covid-19 immunisation. Relevant medical history included: "Factor 5 Leiden" (unspecified if ongoing); "Graves' Disease" (unspecified if ongoing); "Hashimotos' Disease" (unspecified if ongoing); "Arthritis" (unspecified if ongoing); "Asthma" (unspecified if ongoing); "Chronic Polyp Disease" (unspecified if ongoing); "Hypertrophy Nerve Sensitivity" (unspecified if ongoing); "SVT" (unspecified if ongoing); "Hypertrophy Nerve Sensitivity" (unspecified if ongoing); "Known allergies: IV catheter dye" (unspecified if ongoing), notes: Known allergies: Allergic to cipro, IV catheter dye, Cyclobenzaprine, Onions; "Known allergies: Onion" (unspecified if ongoing), notes: Known allergies: Allergic to cipro, IV catheter dye, Cyclobenzaprine, Onions. Concomitant medication(s) included: ALPRAZOLAM. Past drug history included: Cipro, reaction(s): "Known allergies: Allergic to cipro", notes: Known allergies: Allergic to cipro, IV catheter dye, Cyclobenzaprine, Onions; Cyclobenzaprine, reaction(s): "Known allergies: Cyclobenzaprine", notes: Known allergies: Allergic to cipro, IV catheter dye, Cyclobenzaprine, Onions. The following information was reported: LYMPHADENOPATHY (non-serious), outcome "recovering", described as "Swollen lymph node in neck following 1st dose"; TREMOR (non-serious), outcome "unknown", described as "Immediate tremor in bottom lips following 1st dose"; HYPOAESTHESIA (non-serious), outcome "unknown", described as "numbness"; RASH (non-serious), outcome "unknown", described as "Rashes"; PRURITUS (non-serious), outcome "unknown", described as "itching"; TASTE DISORDER (non-serious), outcome "recovering", described as "Medicine Taste". Therapeutic measures were not taken as a result of lymphadenopathy, taste disorder.  Additional information: The patient received the second dose of BNT162B2 (Lot number FA7485) on 30Aug2021 09:00 AM as dose 2 in left arm. The patient did not take any other vaccine in four weeks. Adverse event: Immediate tremor in bottom lips following 1st dose Swollen lymph node in neck following 1st dose Rashes and itching following 1st dose and some numbness Swollen lymph nodes in left underarm and neck following 2nd dose Cold like symptoms (fatigue, stuffiness) following 2nd dose Rashes and itchiness following 2nd dose Medicine Taste in mouth following both doses. Adverse event: Immediate tremor in bottom lips following 1st dose Swollen lymph node in neck following 1st dose Rashes and itching following 1st dose and some numbness Swollen lymph nodes in left underarm and neck following 2nd dose Cold like symptoms (fatigue, stuffiness) following 2nd dose Rashes and itchiness following 2nd dose Medicine Taste in mouth following both doses. The patient did not test Covid post vaccination.  No follow-up attempts are possible. No further information is expected.